IL143671A0 - PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF BREAST CANCER COMPRISING hCG - Google Patents
PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF BREAST CANCER COMPRISING hCGInfo
- Publication number
- IL143671A0 IL143671A0 IL14367199A IL14367199A IL143671A0 IL 143671 A0 IL143671 A0 IL 143671A0 IL 14367199 A IL14367199 A IL 14367199A IL 14367199 A IL14367199 A IL 14367199A IL 143671 A0 IL143671 A0 IL 143671A0
- Authority
- IL
- Israel
- Prior art keywords
- hcg
- treatment
- pharmaceutical compositions
- breast cancer
- breast
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98123817A EP1013281A1 (fr) | 1998-12-15 | 1998-12-15 | hCG therapie pour le traitement du cancer du sein |
| PCT/US1999/029795 WO2000035469A2 (fr) | 1998-12-15 | 1999-12-15 | Therapie a base de gonadotrophine chorionique destinee au traitement du cancer du sein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL143671A0 true IL143671A0 (en) | 2002-04-21 |
Family
ID=8233138
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14367199A IL143671A0 (en) | 1998-12-15 | 1999-12-15 | PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF BREAST CANCER COMPRISING hCG |
| IL143671A IL143671A (en) | 1998-12-15 | 2001-06-11 | Pharmaceuticals for the treatment of breast cancer that contain GCH |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL143671A IL143671A (en) | 1998-12-15 | 2001-06-11 | Pharmaceuticals for the treatment of breast cancer that contain GCH |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7183251B1 (fr) |
| EP (2) | EP1013281A1 (fr) |
| JP (1) | JP2003523311A (fr) |
| AR (1) | AR023726A1 (fr) |
| AT (1) | ATE353664T1 (fr) |
| AU (1) | AU781495B2 (fr) |
| BR (1) | BR9916221A (fr) |
| CA (1) | CA2351726A1 (fr) |
| CY (1) | CY1106525T1 (fr) |
| DE (1) | DE69935156T2 (fr) |
| DK (1) | DK1140147T3 (fr) |
| ES (1) | ES2277461T3 (fr) |
| IL (2) | IL143671A0 (fr) |
| PT (1) | PT1140147E (fr) |
| SI (1) | SI1140147T1 (fr) |
| WO (1) | WO2000035469A2 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008515818A (ja) * | 2004-10-07 | 2008-05-15 | ステム セル セラピューティクス コーポレイション | 妊娠に関連する化合物の投与による多能性幹細胞の増殖の刺激 |
| US8968210B2 (en) * | 2008-10-01 | 2015-03-03 | Covidien LLP | Device for needle biopsy with integrated needle protection |
| US9186128B2 (en) | 2008-10-01 | 2015-11-17 | Covidien Lp | Needle biopsy device |
| US9332973B2 (en) | 2008-10-01 | 2016-05-10 | Covidien Lp | Needle biopsy device with exchangeable needle and integrated needle protection |
| US11298113B2 (en) | 2008-10-01 | 2022-04-12 | Covidien Lp | Device for needle biopsy with integrated needle protection |
| US9782565B2 (en) | 2008-10-01 | 2017-10-10 | Covidien Lp | Endoscopic ultrasound-guided biliary access system |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0160699B1 (fr) | 1983-11-02 | 1992-08-12 | Applied Research Systems Ars Holding N.V. | Production d'hormones heterodimeriques de la fertilite chez l'homme |
| US5677275A (en) | 1994-08-05 | 1997-10-14 | The United States Of America As Represented By The Department Of Health And Human Services | Treatment of cancer with human chorionic gonadotropin |
| US5700781A (en) | 1994-10-04 | 1997-12-23 | Harris; Pamela Jo | Method for treating Kaposi's sarcoma and HIV infections |
| US5997871A (en) * | 1996-06-24 | 1999-12-07 | University Of Maryland Biotechnology Insitute | Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin |
-
1998
- 1998-12-15 EP EP98123817A patent/EP1013281A1/fr not_active Withdrawn
-
1999
- 1999-12-15 AU AU23631/00A patent/AU781495B2/en not_active Ceased
- 1999-12-15 EP EP99967331A patent/EP1140147B1/fr not_active Expired - Lifetime
- 1999-12-15 SI SI9930954T patent/SI1140147T1/sl unknown
- 1999-12-15 WO PCT/US1999/029795 patent/WO2000035469A2/fr active IP Right Grant
- 1999-12-15 JP JP2000587788A patent/JP2003523311A/ja active Pending
- 1999-12-15 US US09/868,196 patent/US7183251B1/en not_active Expired - Lifetime
- 1999-12-15 PT PT99967331T patent/PT1140147E/pt unknown
- 1999-12-15 DK DK99967331T patent/DK1140147T3/da active
- 1999-12-15 BR BR9916221-0A patent/BR9916221A/pt not_active Application Discontinuation
- 1999-12-15 AT AT99967331T patent/ATE353664T1/de active
- 1999-12-15 CA CA002351726A patent/CA2351726A1/fr not_active Abandoned
- 1999-12-15 AR ARP990106407A patent/AR023726A1/es unknown
- 1999-12-15 IL IL14367199A patent/IL143671A0/xx unknown
- 1999-12-15 ES ES99967331T patent/ES2277461T3/es not_active Expired - Lifetime
- 1999-12-15 DE DE69935156T patent/DE69935156T2/de not_active Expired - Lifetime
-
2001
- 2001-06-11 IL IL143671A patent/IL143671A/en not_active IP Right Cessation
-
2007
- 2007-04-12 CY CY20071100514T patent/CY1106525T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000035469A2 (fr) | 2000-06-22 |
| PT1140147E (pt) | 2007-03-30 |
| AR023726A1 (es) | 2002-09-04 |
| CY1106525T1 (el) | 2012-01-25 |
| WO2000035469A3 (fr) | 2000-09-14 |
| AU781495B2 (en) | 2005-05-26 |
| JP2003523311A (ja) | 2003-08-05 |
| DE69935156T2 (de) | 2007-11-22 |
| IL143671A (en) | 2009-08-03 |
| EP1140147A2 (fr) | 2001-10-10 |
| WO2000035469A9 (fr) | 2001-03-22 |
| BR9916221A (pt) | 2001-09-11 |
| EP1013281A1 (fr) | 2000-06-28 |
| EP1140147B1 (fr) | 2007-02-14 |
| CA2351726A1 (fr) | 2000-06-22 |
| ATE353664T1 (de) | 2007-03-15 |
| ES2277461T3 (es) | 2007-07-01 |
| AU2363100A (en) | 2000-07-03 |
| SI1140147T1 (sl) | 2007-06-30 |
| DK1140147T3 (da) | 2007-03-26 |
| US7183251B1 (en) | 2007-02-27 |
| DE69935156D1 (de) | 2007-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1807401A (en) | Compositions and methods for therapy and diagnosis of breast cancer | |
| HUP0200763A2 (en) | Compositions for the treatment and diagnosis of breast cancer and methods for their use | |
| HUP0104717A3 (en) | Compositions and methods for therapy and diagnosis of ovarian cancer | |
| HUP0201187A2 (en) | Use of ecteinascidin743 for producing pharmaceutical compositions suitable for treating cancer | |
| PL354540A1 (en) | Drugs for the treatment of malignant tumours | |
| PL365244A1 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
| EP0942742A4 (fr) | Compositions therapeutiques destinees au traitement du cancer | |
| EP1007535A4 (fr) | Procedes et compositions de diagnostic et de traitement du cancer du sein | |
| IL132287A0 (en) | Compositions and methods for the treatment and diagnosis of breast cancer | |
| AU3391200A (en) | Compositions and methods for breast cancer therapy and diagnosis | |
| HUP9701777A3 (en) | Use of raloxifene for producing pharmaceutical compositions for preventing breast cancer | |
| PL358542A1 (en) | Exemestane for first-line treatment of breast cancer | |
| EP1420814A4 (fr) | Compositions et techniques de therapie et de diagnostic du cancer du sein | |
| HUP0402341A3 (en) | Compositions containing thiazol-2-ylamines for the treatment of cancer | |
| PL366066A1 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
| AU5638400A (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
| IL143671A0 (en) | PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF BREAST CANCER COMPRISING hCG | |
| HUP0200825A2 (en) | Compositions and methods for the treatment and diagnosis of breast cancer | |
| ZA200108256B (en) | Compositions and methods for the treatment and diagnosis of breast cancer. | |
| IL149281A0 (en) | Treatment of cancer | |
| GB9819999D0 (en) | Treatment of cancer | |
| AU2292801A (en) | Compositions and methods for treatment of breast cancer | |
| AU2001280443A1 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
| HUP9902840A3 (en) | Use of lectin for producing pharmaceutical compositions suitable for treatment of cancer | |
| IL138705A0 (en) | Pharmaceutical compositions comprising erythropoietin for treatment of cancer |